Drug-Techs LLC is categorized under Physical Examination and Testing Services in Denver, CO and active since 2000.
Drug-Techs LLC was established in 2000, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physical Examination and Testing Services business, which does work in the B2C market, and is classified as a Physical Examination and Testing Services, under code number 6215110 by the NAICS.
If you are seeking more information, feel free to contact Kevin Bush, Manager at the company’s single location by writing to 8333 Greenwood Boulevard # 215, Denver, Colorado CO 80221 or by phoning (303) 650-4151. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Drug-Techs LLC |
| Contact Person: | Kevin Bush, Manager |
| Address: | 8333 Greenwood Boulevard # 215, Denver, Colorado 80221 |
| Phone Number: | (303) 650-4151 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physical Examination and Testing Services |
| SIC Code: | 8099 |
| NAICS Code: | 6215110 |
| Share This Business: |
Drug-Techs LLC was started in 2000 to provide professional Physical Examination and Testing Services under the SIC code 8099 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Kevin Bush, Manager for inquiries that concern Drug-Techs LLC by calling the company number (303) 650-4151, as your correspondence is most welcome. Additionally, the physical location of the single location of Drug-Techs LLC can be found at the coordinates 39.84804,-104.99667 as well as the street address 8333 Greenwood Boulevard # 215 in Denver, Colorado 80221.
For its online presence, you may visit Drug-Techs LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.